Human RPA activates BLM's bidirectional DNA unwinding from a nick

  1. Zhenheng Qin
  2. Lulu Bi
  3. Xi-Miao Hou
  4. Siqi Zhang
  5. Xia Zhang
  6. Ying Lu
  7. Ming Li
  8. Mauro Modesti
  9. Xu-Guang Xi  Is a corresponding author
  10. Bo Sun  Is a corresponding author
  1. ShanghaiTech University, China
  2. Northwest A&F University, China
  3. Chinese Academy of Sciences, China
  4. Cancer Research Center of Marseille, CNRS UMR7258, Inserm U1068, France
  5. Ecole Normale Supérieure de Cachan, France

Abstract

BLM is a multifunctional helicase that plays critical roles in maintaining genome stability. It processes distinct DNA substrates, but not nicked DNA, during many steps in DNA replication and repair. However, how BLM prepares itself for diverse functions remains elusive. Here, using a combined single-molecule approach, we find that a high abundance of BLMs can indeed unidirectionally unwind dsDNA from a nick when an external destabilizing force is applied. Strikingly, human replication protein A (hRPA) not only ensures that limited quantities of BLMs processively unwind nicked dsDNA under a reduced force but also permits the translocation of BLMs on both intact and nicked ssDNAs, resulting in a bidirectional unwinding mode. This activation necessitates BLM targeting on the nick and the presence of free hRPAs in solution whereas direct interactions between them are dispensable. Our findings present novel DNA unwinding activities of BLM that potentially facilitate its function switching in DNA repair.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1, 3, 4 and 5.

Article and author information

Author details

  1. Zhenheng Qin

    School of Life Science and Technology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Lulu Bi

    School of Life Science and Tehnology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Xi-Miao Hou

    College of Life Sciences, Northwest A&F University, Yangling, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Siqi Zhang

    School of Life Science and Tehnology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Xia Zhang

    School of Life Science and Tehnology, ShanghaiTech University, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Ying Lu

    Institute of Physics, Chinese Academy of Sciences, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Ming Li

    Institute of Physics, Chinese Academy of Sciences, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Mauro Modesti

    Cancer Research Center of Marseille, CNRS UMR7258, Inserm U1068, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4964-331X
  9. Xu-Guang Xi

    Laboratoire de Biologie et Pharmacologie Appliquée, Ecole Normale Supérieure de Cachan, Cachan, France
    For correspondence
    xxi01@ens-cachan.fr
    Competing interests
    The authors declare that no competing interests exist.
  10. Bo Sun

    School of Life Science and Tehnology, ShanghaiTech University, Shanghai, China
    For correspondence
    sunbo@shanghaitech.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4590-7795

Funding

Ministry of Science and Technology of the People's Republic of China (2016YFA0500902)

  • Bo Sun

Ministry of Science and Technology of the People's Republic of China (2017YFA0106700)

  • Bo Sun

The Natural Science Foundation of Shanghai (19ZR1434100)

  • Bo Sun

The French National Cancer Institute (PLBIO2017-167)

  • Mauro Modesti

The French National League Against Cancer (EL2028.LNCC/MaM)

  • Mauro Modesti

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Qin et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,968
    views
  • 550
    downloads
  • 34
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Zhenheng Qin
  2. Lulu Bi
  3. Xi-Miao Hou
  4. Siqi Zhang
  5. Xia Zhang
  6. Ying Lu
  7. Ming Li
  8. Mauro Modesti
  9. Xu-Guang Xi
  10. Bo Sun
(2020)
Human RPA activates BLM's bidirectional DNA unwinding from a nick
eLife 9:e54098.
https://doi.org/10.7554/eLife.54098

Share this article

https://doi.org/10.7554/eLife.54098

Further reading

    1. Structural Biology and Molecular Biophysics
    Manming Xu, Sarath Chandra Dantu ... Shozeb Haider
    Research Article

    The relationship between protein dynamics and function is essential for understanding biological processes and developing effective therapeutics. Functional sites within proteins are critical for activities such as substrate binding, catalysis, and structural changes. Existing computational methods for the predictions of functional residues are trained on sequence, structural, and experimental data, but they do not explicitly model the influence of evolution on protein dynamics. This overlooked contribution is essential as it is known that evolution can fine-tune protein dynamics through compensatory mutations either to improve the proteins’ performance or diversify its function while maintaining the same structural scaffold. To model this critical contribution, we introduce DyNoPy, a computational method that combines residue coevolution analysis with molecular dynamics simulations, revealing hidden correlations between functional sites. DyNoPy constructs a graph model of residue–residue interactions, identifies communities of key residue groups, and annotates critical sites based on their roles. By leveraging the concept of coevolved dynamical couplings—residue pairs with critical dynamical interactions that have been preserved during evolution—DyNoPy offers a powerful method for predicting and analysing protein evolution and dynamics. We demonstrate the effectiveness of DyNoPy on SHV-1 and PDC-3, chromosomally encoded β-lactamases linked to antibiotic resistance, highlighting its potential to inform drug design and address pressing healthcare challenges.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Assmaa Elsheikh, Camden M Driggers ... Show-Ling Shyng
    Research Article

    Pancreatic KATP channel trafficking defects underlie congenital hyperinsulinism (CHI) cases unresponsive to the KATP channel opener diazoxide, the mainstay medical therapy for CHI. Current clinically used KATP channel inhibitors have been shown to act as pharmacochaperones and restore surface expression of trafficking mutants; however, their therapeutic utility for KATP trafficking-impaired CHI is hindered by high affinity binding, which limits functional recovery of rescued channels. Recent structural studies of KATP channels employing cryo-electron microscopy (cryoEM) have revealed a promiscuous pocket where several known KATP pharmacochaperones bind. The structural knowledge provides a framework for discovering KATP channel pharmacochaperones with desired reversible inhibitory effects to permit functional recovery of rescued channels. Using an AI-based virtual screening technology AtomNet followed by functional validation, we identified a novel compound, termed Aekatperone, which exhibits chaperoning effects on KATP channel trafficking mutations. Aekatperone reversibly inhibits KATP channel activity with a half-maximal inhibitory concentration (IC50) ~9 μM. Mutant channels rescued to the cell surface by Aekatperone showed functional recovery upon washout of the compound. CryoEM structure of KATP bound to Aekatperone revealed distinct binding features compared to known high affinity inhibitor pharmacochaperones. Our findings unveil a KATP pharmacochaperone enabling functional recovery of rescued channels as a promising therapeutic for CHI caused by KATP trafficking defects.